KR100837857B1 - Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof - Google Patents
Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof Download PDFInfo
- Publication number
- KR100837857B1 KR100837857B1 KR1020060127971A KR20060127971A KR100837857B1 KR 100837857 B1 KR100837857 B1 KR 100837857B1 KR 1020060127971 A KR1020060127971 A KR 1020060127971A KR 20060127971 A KR20060127971 A KR 20060127971A KR 100837857 B1 KR100837857 B1 KR 100837857B1
- Authority
- KR
- South Korea
- Prior art keywords
- anchovy
- salt
- weight
- bacillus licheniformis
- strain
- Prior art date
Links
- 230000003480 fibrinolytic effect Effects 0.000 title abstract 2
- 230000003308 immunostimulating effect Effects 0.000 title abstract 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 title description 2
- 239000003527 fibrinolytic agent Substances 0.000 title 1
- 241001454694 Clupeiformes Species 0.000 claims abstract description 60
- 235000019513 anchovy Nutrition 0.000 claims abstract description 60
- 150000003839 salts Chemical class 0.000 claims abstract description 36
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000008213 purified water Substances 0.000 claims abstract description 5
- 230000002537 thrombolytic effect Effects 0.000 claims description 19
- 241000251468 Actinopterygii Species 0.000 claims description 9
- 235000019688 fish Nutrition 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000011160 research Methods 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 230000001900 immune effect Effects 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 235000021109 kimchi Nutrition 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 235000021067 refined food Nutrition 0.000 abstract description 2
- 230000008021 deposition Effects 0.000 abstract 1
- 230000005070 ripening Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 15
- 230000004151 fermentation Effects 0.000 description 15
- 244000005700 microbiome Species 0.000 description 14
- 230000017854 proteolysis Effects 0.000 description 12
- 239000003146 anticoagulant agent Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 230000005714 functional activity Effects 0.000 description 5
- 230000005965 immune activity Effects 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- CDVZCUKHEYPEQS-KPXKHRLBSA-N (2s,3r,4r)-2,3,4,5-tetrahydroxypentanal;(2r,3s,4s)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C=O CDVZCUKHEYPEQS-KPXKHRLBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 241000146989 Engraulis japonicus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/20—Fish extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/65—Addition of, or treatment with, microorganisms or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
도 1은 본 발명의 제조공정도를 나타낸다.1 shows a manufacturing process diagram of the present invention.
도 2a는 멸치젓갈 발효과정 중에 분리한 미생물의 단백질 분해능력측정을 나타낸 사진으로서 1% 환원탈지유가 포함된 배지에서의 단백질 분해력 측정을 나타낸 사진이다.Figure 2a is a photograph showing the protein degradation capacity of the microorganism separated during the fermentation anchovy salt fermentation process is a photograph showing the protein degradation capacity in the medium containing 1% reduced skim milk.
도 2b는 멸치젓갈 발효과정 중에 분리한 미생물의 단백질 분해능력측정을 나타낸 사진으로서 fibrin plate법을 이용한 단백질 분해력 측정을 나타낸 사진이다.Figure 2b is a photograph showing the measurement of protein degradation ability of microorganisms isolated during fermentation of anchovy salt, it is a photograph showing the protein degradation capacity using the fibrin plate method.
도 3은 FA0507 균주의 시중판매 멸치젓갈에 적용을 나타낸 사진으로서 왼쪽사진은 시중 판매 멸치젓갈 5 종의 혈전 용해능 실험을 나타낸 것이고, 가운데 사진은 FA0507 균주와 washing buffer, 희석수의 혈전 용해능 실험을 나타낸 것이고 오른쪽 사진은 시중 판매 멸치젓갈 3 종에 FA0507 균주를 혼합하여 혈전 용해능 실험을 나타낸 사진이다.Figure 3 is a photograph showing the application of commercially available anchovy salt of FA0507 strains. The left photo shows the thrombi solubility test of five commercial anchovy salts. The middle photo shows the thrombi solubility test of FA0507 strain, washing buffer and dilution water. The picture on the right is a picture showing the thrombolytic ability test by mixing FA0507 strains with three commercially available anchovy salt.
도 4는 FA0407을 처리한 거식세포의 NO 생성농도를 나타낸 그래프이다. 4 is a graph showing the NO production concentration of macrophages treated with FA0407.
도 5는 FA0407을 처리한 거식세포의 IL-1a 생성농도를 나타낸 그래프이다. Figure 5 is a graph showing the IL-1a production concentration of macrophages treated with FA0407.
본 발명은 멸치젓갈에서 분리한 혈전 용해능 및 면역 활성이 높은 바실러스(Bacillus)균 및 이를 함유한 젓갈에 관한 것이다. 보다 상세하게는 혈전용해능 및 면역세포 활성능이 높은 건강기능 활성을 갖는 바실러스 균주를 멸치젓갈로부터 탐색하고, 건강기능 활성을 갖는 바실러스 균주를 멸치젓갈 제품에 활용하고자 함에 그 목적이 있다.The present invention relates to Bacillus ( Bacillus ) bacteria having high thrombolytic ability and immune activity isolated from anchovy salt and salted salt containing the same. More specifically, the purpose of the present invention is to search for Bacillus strains having high thrombolytic and immune cell activity health functional activities from anchovy salt, and to utilize Bacillus strains with healthy functional activity in anchovy salt products.
멸치젓이란 생멸치를 소금에 절여 3개월 이상 숙성시킨 액상의 젓갈이다. 멸치(학명 Engraulis japonica, 지중해산은 Anchovy라 함)는 청어목 멸치과 바닷물고기로서 몸길이 15㎝ 정도로 몸은 가늘고 길며 약간 납작하다. 연안성 회유어(沿岸性回游魚)이며 플랑크톤을 주식으로 한다. 산란기는 거의 1년 내내 계속되지만 성기(盛期)는 봄부터 여름과 가을의 2회이며, 북방에서는 산란기가 늦고 성기도 1회이다. 알은 길쭉하고 투명한 부유성(浮遊性)이다. 성어(成魚), 치어(稚魚) 모두 생산량이 많고 선망(旋網), 해치망 등으로 어획된다. 말림, 젓, 조림 등으로 만들어 먹으며 가다랭이 낚시 등의 산미끼로 이용되기도 한다. 한국ㅇ중국ㅇ일본 등지에 분포한다.Anchovy salted salted anchovy is a salted salted fish that has been aged for more than 3 months. Anchovy (named Engraulis japonica, Anchovy from the Mediterranean) is herring anchovy and saltwater fish. The body is thin, long and flat. Coastal sashimi (沿岸 性 回 游魚), whose stock is plankton. The spawning season lasts for almost a year, but the penis is two times from spring to summer and autumn. Eggs are elongated and transparent. Both adult and larvae produce a lot of fish and are caught with enamel and hatch nets. It is made of dried foods, salted fish, and stewed foods. It is also used as a bait for bonito fishing. It is distributed in Korea, China, and Japan.
5∼6월에 가장 성숙한 멸치가 우리나라 남해안과 남서해안에서 어획되기 시 작하면 상태가 좋은 멸치는 주로 증숙시켜 건조한 후 건멸치로 만들어 시중에 판매되고, 그 나머지의 멸치는 젓갈로 제조된다. 특히 경상남도, 전라남도, 충청남도, 제주도에서 멸치젓을 주로 담그고 시장도 그 쪽에 많이 형성되어 있다. 멸치젓을 담글 때는 생멸치와 소금을 5 : 3의 비율로 혼합하여 항아리에 넣고 밀봉한다. 멸치젓은 김치를 담글 때 달여서 넣으면 좋고 해초를 데쳐 먹거나 무쳐 먹을 때 넣어도 좋으며 날로 무쳐 먹기도 한다. 날로 무쳐 먹을 멸치젓은 생멸치를 깨끗이 다듬어서 가시를 빼고 담그는 데, 가을에 꺼내어 양념해 먹으면 좋다.When the most mature anchovies are caught in the south and southwest coasts of Korea in May-June, the good anchovies are steamed, dried, dried, and sold on the market. The rest of the anchovies are made with salted fish. In particular, anchovies are mainly immersed in Gyeongsangnam-do, Jeollanam-do, Chungcheongnam-do, and Jeju-do, and many markets are formed there. When soaking anchovy salt, mix raw anchovy and salt in a ratio of 5: 3, put it in a jar and seal it. Anchovy salted kimchi can be added to decoct when you soak it. It can be used to boil or eat seaweed. Raw anchovies are eaten raw, and the raw anchovies are trimmed to remove the thorns.
젓갈은 어패류의 근육이나 내장 등에 다량의 소금을 가한 후 숙성과정에서 자가소화효소나 미생물의 효소작용에 의해 단백질이 분해되어 특유의 맛과 조직감을 갖게되는 전통발효식품이다. 젓갈의 숙성과 발효에 관여하는 미생물은 높은 소금 농도에서 생육할 수 있는 내염성균으로 제품의 영양과 풍미에 영향을 미친다고 알려져 있다. 젓갈 미생물의 건강 기능활성에 대해서는 혈전용해 활성을 나타내는 젓갈 미생물과 관련하여서는 발표된 연구사례가 있으나 아직까지 연구가 많이 이루어지지 않고 있고, 청국장 미생물의 혈전용해 활성 및 면역활성능과 관련된 특허가 이미 본 연구진에 의하여 등록이 된 상태이나 (발명특허 10-0588521), 건강 기능활성 젓갈 미생물을 젓갈 제품에 응용하여 조사한 예는 아직까지 없는 실정이다.Salted seafood is a traditional fermented food that has a distinctive taste and texture by adding a large amount of salt to the muscles and intestines of fish and shellfish and then decomposing the protein by the enzyme action of autophagy or microorganisms during aging. Microorganisms involved in fermentation and fermentation of salted fish are salt-resistant bacteria that can grow at high salt concentrations and are known to affect the nutrition and flavor of products. As for the health functional activity of salted microorganisms, there have been published research cases related to salted microorganisms showing thrombolytic activity, but there are not many studies yet. Patents related to the thrombolytic activity and immunological activity of Cheonggukjang microorganism have already been seen. Although the state has been registered by the researchers (Invention Patent 10-0588521), there have been no examples of the application of the health functional active salted microorganisms to the salted fish products.
본 발명에서는 멸치젓갈 발효 혹은 숙성 과정 중에서 분리한 326개의 미생물 중에 단백질 분해능이 우수하고, 면역활성이 높은 Bacillus 균주를 선발하고, 시중 판매 멸치젓갈에 적용하여 그 기능성을 확인함으로써 균주의 활용여부를 확인하였다.In the present invention, Bacillus strains having excellent protein resolution and high immune activity among 326 microorganisms isolated during fermentation or fermentation of anchovy are selected, and applied to commercially available anchovy salt to confirm its functionality. It was.
본 발명은 멸치젓으로부터 일반세균수를 측정하고 표준 한천배지로부터 미생물을 순수 분리하여 skim milk배지로부터 단백질분해능력이 우수한 균주와, 혈전 용해 활성이 높고, 면역활성화능이 좋은 FA0407 균주를 선발한다(도 1 참조).The present invention measures the general bacterial counts from anchovy and purely isolates the microorganisms from the standard agar medium to select strains with excellent protein degradation ability from skim milk medium, high thrombolytic activity, and good immuno-activating FA0407 strain (Fig. 1). Reference).
본 발명은 멸치젓갈에서 분리한 신균주 Bacillus licheniformis FA0407 KCTC 10752BP(한국생명공학연구원 유전자은행에 2004년 12월 20일 기탁)를 나타낸다.The present invention represents a new strain Bacillus licheniformis FA0407 KCTC 10752BP (deposited Dec. 20, 2004 to the Korea Biotechnology Research Institute Gene Bank) isolated from anchovy salt.
본 발명의 멸치젓갈에서 분리한 신균주 Bacillus licheniformis FA0407(KCTC 10752BP)는 단백질 분해능이 우수하다.The new strain Bacillus licheniformis FA0407 (KCTC 10752BP) isolated from anchovy salt of the present invention has excellent protein resolution.
본 발명의 멸치젓갈에서 분리한 신균주 Bacillus licheniformis FA0407(KCTC 10752BP)는 혈전용해활성이 우수하다.The new strain Bacillus licheniformis FA0407 (KCTC 10752BP) isolated from anchovy salt of the present invention has excellent thrombolytic activity.
본 발명의 멸치젓갈에서 분리한 신균주 Bacillus licheniformis FA0407(KCTC 10752BP)는 면역활성능이 우수하다.The bacterium Bacillus licheniformis FA0407 (KCTC 10752BP) isolated from anchovy salt of the present invention has excellent immune activity.
본 발명은 Bacillus licheniformis FA0407(KCTC 10752BP)균주를 약제학적으로 허용하는 범위내에서 의약품으로 사용하는 방법을 포함한다.The present invention includes a method of using Bacillus licheniformis FA0407 (KCTC 10752BP) strain as a medicament within a pharmaceutically acceptable range.
본 발명은 Bacillus licheniformis FA0407(KCTC 10752BP)균주를 식품학적으로 허용하는 범위내에서 건강기능식품으로 사용하는 방법을 포함한다.The present invention includes a method of using Bacillus licheniformis FA0407 (KCTC 10752BP) strain as a health functional food within a food acceptable range.
본 발명은 Bacillus licheniformis FA0407(KCTC 10752BP) 균주를 함유한 멸 치젓갈을 포함한다. The present invention includes anchovy salt containing Bacillus licheniformis FA0407 (KCTC 10752BP) strain.
본 발명은 Bacillus licheniformis FA0407(KCTC 10752BP) 균주를 함유한 멸치젓갈의 제조방법을 포함한다. The present invention includes a method for preparing anchovy salted fish containing Bacillus licheniformis FA0407 (KCTC 10752BP) strain.
본 발명의 Bacillus licheniformis FA0407(KCTC 10752BP) 균주를 함유한 멸치젓갈은 생멸치 5∼6중량부와, 소금 3∼4중량부와 정제수 1∼2중량부 및 Bacillus licheniformis FA0407(KCTC 10752BP)균주를 혼합하여 상온에서 6개월 이상, 바람직하게는 6∼12개월 숙성시켜 제조할 수 있다.Anchovy salt containing Bacillus licheniformis FA0407 (KCTC 10752BP) strain of the present invention by mixing 5-6 parts by weight of raw anchovy, 3-4 parts by weight of salt, 1-2 parts by weight of purified water and Bacillus licheniformis FA0407 (KCTC 10752BP) strain It can be prepared by aging at room temperature for 6 months or more, preferably 6-12 months.
이하 본 발명의 내용을 실시예 및 시험예를 통하여 구체적으로 설명한다. 그러나, 이들은 본 발명을 보다 상세하게 설명하기 위한 것으로 본 발명의 권리범위가 이들에 의해 한정되는 것은 아니다.Hereinafter, the content of the present invention will be described in detail through examples and test examples. However, these are intended to explain the present invention in more detail, and the scope of the present invention is not limited thereto.
<실시예 1><Example 1>
멸치젓 제조업체(경동시장)에서 구입한 멸치젓 60kg을 플라스틱 통에 옮겨 담은 후, 한국식품연구원 건물 옆 통풍이 잘되고 빛이 들지 않는 반 지하 방에 보관하면서, 0일 째와 15일 째에 그리고 그 다음부터는 한달 간격으로 시료를 채취하여 멸치젓 시료의 균수 및 일반 화학성분의 조사결과는 표 1에서 보여주는 것과 같다. 60kg of anchovy salt from anchovy manufacturer (Kyungdong Market) was transferred to a plastic container, and then stored in a well-ventilated, non-lighting, semi-underground room next to the Korea Food Research Institute building on the 0th and 15th days. Samples are taken at monthly intervals and the results of the investigation of the bacterial counts and general chemical composition of anchovy samples are shown in Table 1.
표 1. 멸치젓의 발효기간 중 호기성균과 이화학적 변화Table 1. Aerobic and Physicochemical Changes of Anchovy Sauce during Fermentation
이들 일반세균수 계수가 완료된 표준 한천배지로부터 25-50개 정도의 집락을 형성한 plate를 선정, 시료 당 50개 정도의 미생물을 순수 분리하였고, 집락 및 세포의 형태학적인 성질조사와 간이동정(Gram staining, Catalase test, Oxidase test)을 실시하였다. 5개월 간의 젓갈 숙성 기간 중 미생물 균총의 변화는 표 2에서 보여주는 것과 같다. 표 2에서 볼 수 있는 것과 같이 멸치젓갈의 2개월 숙성 이후에는 그람음성(Gram positive), 촉매효소음성(Catalase negative), 산화효소음성(Oxidase positive)인 간균 및 구균들이 주점종 미생물 (main microflora)인 것을 알 수가 있다.Plates with 25-50 colonies were selected from the standard agar media with the complete count of bacteria, and 50 microorganisms were isolated from each sample, and the morphological properties of the colonies and cells were examined. staining, Catalase test, Oxidase test) were performed. Changes of microbial flora in five months of fermentation are shown in Table 2. As shown in Table 2, after two months of fermentation of anchovy salt, Gram negative, Catalytic negative, Oxidase positive bacillus and cocci were the main microflora. It can be seen that.
표 2. 발효기간 중 균수의 변화Table 2. Changes in Number of Cells During Fermentation
<실시예 2><Example 2>
이들 분리된 미생물들을 이용하여 skim milk 1% 첨가된 표준한천 배지에서의 단백질 분해력을 측정하였으며, 단백질 분해활성이 가장 높은 네 균주를 선발하여 fibrin plate (0.01M phosphate buffered saline (pH 7.25), fibrinogen 0.3%, thrombin 20 unit)를 이용하여 혈전 용해력을 관찰하였다. 이들 균주들의 단백질 분해력 및 혈전용해활성을 측정한 결과는 도 2a, 도 2b에서 보여주는 것과 같다. 도 2a, 도 2b에서 볼 수 있는 것과 같이 FA0407균주의 단백질 분해력 및 혈전용해 활성이 가장 높은 것을 알 수 있다. Using the isolated microorganisms, proteolytic ability was measured in standard agar medium supplemented with
도 2a는 멸치젓갈 발효과정 중에 분리한 미생물의 단백질 분해능력측정을 나타낸 사진으로서 1% 환원탈지유가 포함된 배지에서의 단백질 분해력 측정을 나타낸 사진이다.Figure 2a is a photograph showing the protein degradation capacity of the microorganism separated during the fermentation anchovy salt fermentation process is a photograph showing the protein degradation capacity in the medium containing 1% reduced skim milk.
도 2b는 멸치젓갈 발효과정 중에 분리한 미생물의 단백질 분해능력측정을 나 타낸 사진으로서 fibrin plate법을 이용한 단백질 분해력 측정을 나타낸 사진이다.Figure 2b is a photograph showing the protein degradation capacity of the microorganisms isolated during the fermentation process of anchovy salt is a photograph showing the protein degradation capacity using the fibrin plate method.
혈전 용해 활성이 높은 FA0407 균주를 시중판매 멸치젓갈에 적용하여 균주의 활용가능성에 대해 알아 본 결과는 도 3에서 보여주는 것과 같다. 시중판매 멸치젓갈 5종 (A, B, C, D, E)을 구입하여 혈전 용해능이 나타나지 않는 세 개의 제품 (A, B, C)에 FA0507 균주를 107 농도가 되도록 혼합하여 혈전 용해능을 측정한 결과 세 개의 제품 모두에서 높은 혈전 용해능 활성을 보이는 것을 알 수 있다(도 3 참조).FA0407 strains with high thrombolytic activity were applied to commercially available anchovy salt, and the results of the study were shown as shown in FIG. 3. Five kinds of anchovy saltfish (A, B, C, D, E) on the market were purchased and three products (A, B, C) that do not exhibit thrombolytic ability were mixed with FA0507 strain to have a concentration of 10 7 . As a result, it can be seen that all three products show high thrombolytic activity (see FIG. 3).
<실시예 3><Example 3>
시중 판매 멸치젓갈에 적용하여 혈전 용해능이 있는 것으로 나타난 FA0507 균주의 면역활성화능을 알아보기 위하여 NO의 생성량과 IL-1a의 생성 능을 측정하였다. 측정 결과 도 4 및 도 5에서 볼 수 있는 것과 같이 농도에 비례하여 NO의 생성량이 증가하고 있고(도 4 참조), 농도에 비례하여 IL-1a의 생성량이 증가함을 나타내고 있으며(도 5 참조), 이것은 FA0407균주의 면역활성화 효과가 있음을 보여주고 있다(도 4 및 도 5 참조).The amount of NO production and IL-1a production were measured to determine the immunoactivating ability of FA0507 strains that were found to have thrombolytic ability by application to commercial anchovy salt. As a result of the measurement, as shown in FIGS. 4 and 5, the amount of NO produced is increased in proportion to the concentration (see FIG. 4), and the amount of IL-1a is increased in proportion to the concentration (see FIG. 5). This shows that there is an immunoactivating effect of strain FA0407 (see FIGS. 4 and 5).
이상의 단백질 분해력, 혈전용해 활성 및 면역활성이 높은 균주 FA0407의 생화학적 시험 및 부분 16S rRNA sequencing을 통하여 동정한 결과 FA0407균주는 Bacillus licheniformis로 동정되었는데, 표 3은 FA0407 균주의 동정 결과를 보여주고 있다.As a result of biochemical test and partial 16S rRNA sequencing of strain FA0407 having high protein degradation, thrombolytic and immuno-activity, the strain FA0407 was identified as Bacillus licheniformis . Table 3 shows the results of the identification of FA0407 strain.
표 3. FA0407균주의 동정 결과Table 3. Identification results of strain FA0407
이상과 같이 멸치젓갈에서 분리한 Bacillus sp. 를 이용하여 건강기능 활성 능력에 대한 조사 결과 FA0407 균주는 혈전용해 활성 및 면역활성능을 가지고 있을 뿐 아니라 멸치젓갈에 첨가 하였을 때에도 계속적으로 혈전용해 활성을 가지고 있는 것으로 밝혀져 FA0407 균주를 이용한 기능활성 멸치젓갈의 제조가 가능하리라 본다. Bacillus licheniformis로 동정되어진 FA0407 균주는 한국생명공학 연구원 유전자은행에 2004년 12월 20일, 기탁번호 KCTC 10752BP로 동 균주에 대한 특허균주 기탁이 완료되었다.As described above, Bacillus sp. Investigations on the health functional activity using FA0407 strains not only have thrombolytic activity and immune activity, but also have thrombolytic activity even when added to anchovy salt. It seems that the production of. The FA0407 strain, identified as Bacillus licheniformis , was deposited with the KCTC 10752BP on December 20, 2004 to the Korea Biotechnology Research Institute Gene Bank.
<적용예 1><Application example 1>
추자도에서 어획한 생멸치를 구입하여 생멸치 5.5중량부와, 소금 3.5중량부와 정제수 1중량부 및 Bacillus licheniformis FA0407(KCTC 10752BP)균주를 혼합하여 상온에서 4개월 이상 숙성시켜 멸치젓을 얻었다.Buy fresh anchovies from Chujado and buy 5.5 parts by weight of fresh anchovy, 3.5 parts by weight of salt, 1 part by weight of purified water, and Bacillus licheniformis FA0407 (KCTC 10752BP) strains were mixed and aged at room temperature for at least 4 months to obtain anchovy.
<적용예 2><Application example 2>
남해안에서 어획된 생멸치 6중량부와, 소금 4중량부와 정제수 2중량부 및 Bacillus licheniformis FA0407(KCTC 10752BP)균주를 혼합하여 상온에서 6개월 이상 숙성시켜 멸치젓을 얻었다.6 parts by weight of fresh anchovies, 4 parts by weight of salt, 2 parts by weight of purified water, and Bacillus licheniformis FA0407 (KCTC 10752BP) strains were mixed at room temperature and aged for at least 6 months to obtain anchovy.
<시험예>; 관능검사<Test Example>; Sensory evaluation
본 발명의 적용예와 같이 담은 멸치젓과 시중에서 유통중인 멸치젓(특급품)의 관능적인 맛 비린내, 구수함을 비교하였던 바, 동등 이상의 수준이었다.As an application example of the present invention, the anchovy taste, fishy taste, and sourness of anchovy marinated and anchovy chopsticks on the market (commodity) were compared.
본 발명의 균주는 혈전용해 활성 및 면역활성능을 가지고 있으므로 이들 균주를 이용하면 맛과 기능활성이 우수한 멸치젓갈을 제조할 수 있을 뿐만 아니라, 다른 김치나 가공식품에도 사용하더라도 기능성이 우수한 식품을 제공할 수 있다Since the strains of the present invention have thrombolytic activity and immunological activity, using these strains can not only produce anchovy salt with excellent taste and functional activity, but also provide food with excellent functionality even when used in other kimchi or processed foods. can do
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060127971A KR100837857B1 (en) | 2006-12-14 | 2006-12-14 | Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060127971A KR100837857B1 (en) | 2006-12-14 | 2006-12-14 | Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100837857B1 true KR100837857B1 (en) | 2008-06-13 |
Family
ID=39771179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060127971A KR100837857B1 (en) | 2006-12-14 | 2006-12-14 | Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100837857B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101083356B1 (en) | 2008-11-11 | 2011-11-15 | 한국식품연구원 | Microorganisms for Improving Blood Stream, and functional food composition including the same |
KR101278617B1 (en) * | 2010-12-29 | 2013-06-25 | 대한민국 | A novel strain of Bacillus licheniformis SF5-1 having excellent protease activity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR980009454A (en) * | 1996-07-10 | 1998-04-30 | 공인수 | A thrombolytic enzyme derived from a strain of Bacillus sp. |
KR19990011607A (en) * | 1997-07-18 | 1999-02-18 | 한영호 | Method for preparing Aspergillus duck mutant strain for high activity protease production |
KR20040044300A (en) * | 2002-11-21 | 2004-05-28 | 학교법인 한마학원 | Composition containing Lactococcus lactis NK24 (KFCC 11315) for stomach disorder |
-
2006
- 2006-12-14 KR KR1020060127971A patent/KR100837857B1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR980009454A (en) * | 1996-07-10 | 1998-04-30 | 공인수 | A thrombolytic enzyme derived from a strain of Bacillus sp. |
KR19990011607A (en) * | 1997-07-18 | 1999-02-18 | 한영호 | Method for preparing Aspergillus duck mutant strain for high activity protease production |
KR20040044300A (en) * | 2002-11-21 | 2004-05-28 | 학교법인 한마학원 | Composition containing Lactococcus lactis NK24 (KFCC 11315) for stomach disorder |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101083356B1 (en) | 2008-11-11 | 2011-11-15 | 한국식품연구원 | Microorganisms for Improving Blood Stream, and functional food composition including the same |
KR101278617B1 (en) * | 2010-12-29 | 2013-06-25 | 대한민국 | A novel strain of Bacillus licheniformis SF5-1 having excellent protease activity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101979500B (en) | Staphylococcus xylosus YG-27 and application thereof to preparation of fish-fermented sausage | |
Tajima et al. | Isolation and pathogenicity of the causative bacterium of spotting disease of sea urchin Strongylocentrotus intermedius | |
CN101333499A (en) | Complex active bacterial biological water purifying a gent and method for preparing same | |
CN1369005A (en) | New bifidobacteria preventing diarrhea caused by pathogenic bacteria | |
CN111394272A (en) | Brevibacillus laterosporus and application thereof | |
CN109329787B (en) | Processing method for reducing allergic protein sensitization of freshwater fish | |
CN101621938B (en) | Method for processing of fish egg and processed fish egg produced by the method | |
KR100837857B1 (en) | Bacillus sp., isolated from meolchi-jeot, having fibrinolytic, immunostimulating activities and jeot-kal products containing thereof | |
CN117264854B (en) | Lactobacillus plantarum and application thereof | |
JPWO2005080550A1 (en) | Nisin high production lactic acid bacteria and its selection method | |
JP2004298080A (en) | Feed for fish and shellfish, and method for producing the same | |
KR20070071911A (en) | Novel lactobacillus sakei and use thereof | |
Thapa | Studies on microbial diversity associated with some fish products of the Eastern Himalayas | |
CN106036574A (en) | Starter culture added pseudosciaena crocea curing method | |
JP6261664B2 (en) | Lyophilized product containing Lactobacillus plantarum LLP5193, which is excellent in acid resistance, bile resistance and cell adhesion ability, as an active ingredient | |
CN114657082B (en) | Lactococcus lactis and application thereof | |
KR102189029B1 (en) | Manufacturing method for fermented fish sauce using novel Bacillus velezensis L2 | |
CN107602686A (en) | A kind of polypeptide resistant to gram-positive bacteria | |
KR102239073B1 (en) | Novel Bacillus velezensis L2 separated from fermented broth of anchow and Fish sauce prepared by using the same | |
KR102189031B1 (en) | Manufacturing method for fermented fish sauce dried yellow corvina using novel Bacillus velezensis L2 | |
KR20040013654A (en) | The fishery fermented food using by anti helicobactor lactobacillus and manufacturing method of the same | |
KR100273742B1 (en) | Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) | |
Rad et al. | Isolation and characterization of Vibrio (Listonella) anguillarum from catfish | |
JP2002330740A (en) | Method for spore bearing bacterium sterilization | |
CN112662582B (en) | Marine bacterium HNB 15 for producing cellulase, microbial preparation thereof and degradation method of natural cellulose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130605 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140602 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |